Prothena reported $11.99M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Akebia Therapeutics AKBA:US USD 30.92M 1.89M
ALKERMES ALKS:US USD 152.78M 2.4M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.29B 40M
Biogen BIIB:US USD 563.3M 9.3M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Exelixis EXEL:US USD 114.98M 7.78M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Intra Cellular Therapies ITCI:US USD 88.38M 11.94M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
Macrogenics MGNX:US USD 15.35M 1.69M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Prothena PRTA:US USD 11.99M 963K
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Vital Therapies VTL:US USD 3.58M 493K
Xoma XOMA:US USD 4.79M 916K
YTE INCY:US USD 266.46M 13.18M